US Patent Issued to ONCO3R Therapeutics on Aug. 19 for "Benzamide-substituted bicyclic imidazo- and pyrazolo-fused -pyridine, -pyrimide, and -pyridazine compounds for treatment of inflammatory diseases" (French, Swiss Inventors)

ALEXANDRIA, Va., Aug. 20 -- United States Patent no. 12,391,679, issued on Aug. 19, was assigned to ONCO3R Therapeutics BV (Brussels).

"Benzamide-substituted bicyclic imidazo- and pyrazolo-fused -pyridine, -pyrimide, and -pyridazine compounds for treatment of inflammatory diseases" was invented by Luke Jonathan Alvey (Romainville, France), Denis Bucher (Rheinfelden, Switzerland), Nicolas Desroy (Romainville, France), Helene Marie Jary (Romainville, France), Christophe Peixoto (Romainville, France), Taoues Temal-Laib (Romainville, France), Amynata Tirera (Romainville, France), Florence Marie-Emilie Bonnaterre (Romainville, France) and Beranger Duthion (Romainville, France).

According to the abstract* released by the U.S. Patent & Trademark...